Related Experiment Video
Updated: Aug 17, 2026
In vivo Imaging of Transgenic Leishmania Parasites in a Live Host
Published on: July 28, 2010
[Immunologic indices in a varying course of lepromatous leprosy]
Insights
In lepromatous leprosy patients, reduced lymphocyte function indicates active disease. Restored function predicts relapse-free recovery, aiding in identifying patients at risk for leprosy relapse.
Area of Science:
- Immunology
- Infectious Diseases
- Dermatology
Background:
- Leprosy, particularly the lepromatous type, significantly impacts immune cell function.
- Lymphocyte proliferation and suppressor activities are crucial for immune regulation in infectious diseases.
Purpose of the Study:
- To investigate lymphocyte proliferative and regulatory functions in lepromatous leprosy patients.
- To determine if immune function changes correlate with disease activity and relapse.
- To identify potential biomarkers for predicting leprosy relapse.
Main Methods:
- Assessing lymphocyte response to mitogens in patients with active lepromatous leprosy.
- Evaluating lymphocyte suppressor functions during disease regression.
- Comparing immune profiles of patients with and without a history of relapses.
Main Results:
- Patients with active lepromatous leprosy exhibit decreased lymphocyte response to mitogens and reduced suppressor functions.
- Immune functions normalize in relapse-free patients during disease regression.
- Patients with a history of relapses maintain diminished lymphocyte functions.
Conclusions:
- Lymphocyte proliferative and suppressor functions are key indicators of lepromatous leprosy activity.
- These cell-mediated immunity characteristics can identify patients at higher risk for disease relapse.
- Monitoring lymphocyte function may aid in personalized leprosy management strategies.
Abstract:
The study of the proliferative and regulatory functions of lymphocytes in patients with lepra of the lepromatous type has shown that at the active stage of the disease both the response of lymphocytes to mitogens and their suppressor functions are decreased. During the regression of the disease these characteristics are restored to the normal level only in patients with the relapse-free course of the disease, while patients with relapses in their medical history retain the low level of such characteristics. It is expedient to use these cell-mediated immunity characteristics as signs permitting the formation of risk groups of patients who may expect the relapse of the disease.
More Related Videos
06:13Enzyme-linked Immunospot Assay (ELISPOT): Quantification of Th-1 Cellular Immune Responses Against Microbial Antigens
Published on: November 24, 2010
10:32Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice
Published on: March 23, 2014
